Power calculations and placebo effect for future clinical trials in progressive supranuclear palsy

Autor: Stamelou, M, Schöpe, J, Wagenpfeil, S, Del Ser, T, Bang, J, Lobach, IY, Luong, P, Respondek, G, Oertel, WH, Boxer, A, Höglinger, GU, Williams, D, Lafontaine, AL, Marras, C, Jog, M, Panisset, M, Lang, A, Parker, L, Stewart, AJ, Corvol, JC, Azulay, JP, Couratier, P, Mollenhauer, B, Lorenzl, S, Ludolph, A, Benecke, R, Hoglinger, G, Lipp, A, Reichmann, H, Woitalla, D, Chan, D, Zermansky, A, Burn, D, Lees, A, Miller, BL, Lobach, IV, Roberson, E, Honig, L, Zamrini, E, Pahwa, R, Bordelon, Y, Driver-Dunkley, E, Lessig, S, Lew, M, Womack, K, Boeve, B, Ferrara, J, Hillis, A, Kaufer, D, Kumar, R, Xie, T, Gunzler, S, Zesiewicz, T, Dayalu, P, Golbe, L, Grossman, M, Jankovic, J, McGinnis, S, Santiago, A, Tuite, P, Isaacson, S, Leegwater-Kim, J, Litvan, I, Knopman, DS, Schneider, LS, Doody, RS, Koestler, M, Jack, CR, Van Deerlin, V, Randolph, C, Gozes, I, Whitaker, S, Hirman, J, Gold, M, Morimoto, BH, Gómez, JC, Tijero, B, Berganzo, K, García de Yebenes, J, Lopez Sendón, JL, Garcia, G, Tolosa, E, Buongiorno, MT, Bargalló, N, Burguera, JA, Martinez, I, Ruiz-Martínez, J, Narrativel, I

Publikováno v: Stamelou, M; Schöpe, J; Wagenpfeil, S; Del Ser, T; Bang, J; Lobach, IY; et al.(2016). Power calculations and placebo effect for future clinical trials in progressive supranuclear palsy. Movement Disorders, 31(5), 742-747. doi: 10.1002/mds.26580. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/9hh04359

© 2016 International Parkinson and Movement Disorder Society. Background: Two recent randomized, placebo-controlled trials of putative disease-modifying agents (davunetide, tideglusib) in progressive supranuclear palsy (PSP) failed to show efficacy,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::e4444575c64d10ef54a6c34969396d32
http://www.escholarship.org/uc/item/9hh04359

Las amiloidosis cerebrales y las demencias

Autor: García de Yébenes, J., Rubio, I.

Publikováno v: In Revista clinica espanola 2006 206(11):573-575

Tideglusib reduces progression of brain atrophy in progressive supranuclear palsy in a randomized trial.

Autor: Höglinger, Günter U., Huppertz, Hans‐Jürgen, Wagenpfeil, Stefan, Andrés, María V, Belloch, Vincente, León, Teresa, Ser, Teodoro, Gmez, J.C., Tijero, B., Villoria, R., García de Yebenes, J., Lopez Sendón, J.L., Tolosa, E., Buongiorno, M.T., Bargalló, N., Burguera, J.A., Martinez, I., Ruiz‐Martínez, J., Villanua, J., Vivancos, F.

Publikováno v: Movement Disorders; Apr2014, Vol. 29 Issue 4, p479-487, 10p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.